AstraZeneca holds talks with US cancer drug developer in $400bn merger

1 day ago

Bristol Myers Squibb tie-up would be one of biggest-ever pharma deals and create world’s fourth-largest drugmaker

Britain’s biggest drugmaker, AstraZeneca, is understood to be in discussions to take over its US rival Bristol Myers Squibb in a deal that would create a near-$400bn (£300bn) pharmaceutical group.

AstraZeneca, run by Pascal Soriot, its longtime chief executive, is the second-biggest listed company in the UK, with a market value of nearly £196bn before the news broke. BMS, headquartered in Princeton and known for its cancer treatments, is worth $133bn.

Continue reading...
Click here to Read More
Previous Article
Red Cross visits Aung San Suu Kyi after Myanmar military pushed to prove she is alive
Next Article
‘You literally can’t’: AI startup Orchid sparks backlash over its ‘second brain’ assistant

Related World Updates:

Are you sure? You want to delete this comment..! Remove Cancel

Comments (0)

    Leave a comment